Felix Theeuwes

2007

In 2007, Felix Theeuwes earned a total compensation of $1.2M as Chairman and Chief Scientific Officer at DURECT, a 21% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$187,961
Option Awards$585,323
Salary$442,260
Other$10,477
Total$1,226,021

Theeuwes received $585.3K in option awards, accounting for 48% of the total pay in 2007.

Theeuwes also received $188K in non-equity incentive plan, $442.3K in salary and $10.5K in other compensation.

Rankings

In 2007, Felix Theeuwes' compensation ranked 3,514th out of 8,700 executives tracked by ExecPay. In other words, Theeuwes earned more than 59.6% of executives.

ClassificationRankingPercentile
All
3,514
out of 8,700
60th
Division
Manufacturing
1,251
out of 3,314
62nd
Major group
Chemicals And Allied Products
237
out of 746
68th
Industry group
Drugs
130
out of 546
76th
Industry
Pharmaceutical Preparations
98
out of 364
73rd
Source: SEC filing on April 29, 2010.

Theeuwes' colleagues

We found four more compensation records of executives who worked with Felix Theeuwes at DURECT in 2007.

2007

James Brown

DURECT

Chief Executive Officer

2007

Su Yum

DURECT

Executive Vice President, Pharmaceutical Systems R&D

2007

Peter Langecker

DURECT

Chief Medical Officer

2007

Matthew Hogan

DURECT

Chief Financial Officer

News

You may also like